Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Accounts Payables (2020 - 2025)

RxSight (RXST) has disclosed Accounts Payables for 6 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables rose 16.55% year-over-year to $5.3 million, compared with a TTM value of $5.3 million through Dec 2025, up 16.55%, and an annual FY2025 reading of $5.3 million, up 16.55% over the prior year.
  • Accounts Payables was $5.3 million for Q4 2025 at RxSight, up from $3.4 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $7.1 million in Q1 2025 and bottomed at $1.7 million in Q4 2021.
  • Average Accounts Payables over 5 years is $3.8 million, with a median of $3.9 million recorded in 2023.
  • The sharpest move saw Accounts Payables soared 146.72% in 2022, then crashed 34.29% in 2025.
  • Year by year, Accounts Payables stood at $1.7 million in 2021, then skyrocketed by 53.64% to $2.6 million in 2022, then surged by 48.86% to $3.9 million in 2023, then increased by 17.63% to $4.5 million in 2024, then increased by 16.55% to $5.3 million in 2025.
  • Business Quant data shows Accounts Payables for RXST at $5.3 million in Q4 2025, $3.4 million in Q3 2025, and $3.3 million in Q2 2025.